Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Hiroyo Kuwabara; Kirsten Westerhout; Maarten Treur; Karin Cerri; Joerg Mahlich; Hiroshi Yatsuhashi

doi:10.3111/13696998.2015.1029492

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Journal of Medical Economics ◽

10.3111/13696998.2015.1029492 ◽

2015 ◽

Vol 18 (7) ◽

pp. 502-511 ◽

Cited By ~ 8

Author(s):

Hiroyo Kuwabara ◽

Kirsten Westerhout ◽

Maarten Treur ◽

Karin Cerri ◽

Joerg Mahlich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Treatment Naïve ◽

Peginterferon And Ribavirin

Download Full-text

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Cited By ~ 14

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

P1215 MANAGEMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 TREATMENT-NAIVE PATIENTS IN AN ERA OF RISING OPPORTUNITIES AND COSTS – A COST-EFFECTIVENESS ANALYSIS OF TREATMENT OPTIONS

Journal of Hepatology ◽

10.1016/s0168-8278(14)61375-1 ◽

2014 ◽

Vol 60 (1) ◽

pp. S493 ◽

Cited By ~ 1

Author(s):

P.A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

S. De Salvia ◽

M. Vinci ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis

Digestive and Liver Disease ◽

10.1016/j.dld.2014.01.028 ◽

2014 ◽

Vol 46 ◽

pp. e11

Author(s):

P.A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

S. De Salvia ◽

S. Okolicsanyi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12871 ◽

2014 ◽

Vol 40 (6) ◽

pp. 657-675 ◽

Cited By ~ 50

Author(s):

S. Saab ◽

S. C. Gordon ◽

H. Park ◽

M. Sulkowski ◽

A. Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Ledipasvir / Sofosbuvir for The Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups

Value in Health ◽

10.1016/j.jval.2015.09.1966 ◽

2015 ◽

Vol 18 (7) ◽

pp. A585 ◽

Cited By ~ 2

Author(s):

J Félix ◽

J Almeida ◽

D Ferreira ◽

M Mota ◽

M Afonso-Silva ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Applied Health Economics and Health Policy ◽

10.1007/s40258-012-0007-8 ◽

2013 ◽

Vol 11 (1) ◽

pp. 65-78 ◽

Cited By ~ 28

Author(s):

Elamin H. Elbasha ◽

Jagpreet Chhatwal ◽

Shannon A. Ferrante ◽

Antoine C. El Khoury ◽

Pedro A. Laires

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-Effectiveness Analysis Of A Personalized Therapy For Genotype 1, Naive, Chronic Hepatitis C Patients In Italy

Value in Health ◽

10.1016/j.jval.2014.08.819 ◽

2014 ◽

Vol 17 (7) ◽

pp. A366

Author(s):

S. Iannazzo ◽

P. Colombatto ◽

F. Bonino ◽

M.R. Brunetto

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Personalized Therapy ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Patients

Download Full-text

Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.09.005 ◽

2020 ◽

Vol 21 ◽

pp. 164-171

Author(s):

Asrul Akmal Shafie ◽

Muhammad Radzi Abu Hassan ◽

Siew Chin Ong ◽

Suchin Virabhak ◽

Yuri Sanchez Gonzalez

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-effectiveness analysis of glecaprevir/pibrentasvir regimen for treating Chinese patients with chronic hepatitis C genotype 1 and genotype 2 infection

Annals of Palliative Medicine ◽

10.21037/apm-21-863 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Hui-Jun Zhou ◽

Gang Wu ◽

Ji-Ming Li ◽

Nasheen Naidoo ◽

Yan-Xiang Xie ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Chinese Patients ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Genotype 2

Download Full-text

Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

Medicina Clínica (English Edition) ◽

10.1016/j.medcle.2015.09.005 ◽

2016 ◽

Vol 146 (2) ◽

pp. 61-64 ◽

Cited By ~ 1

Author(s):

Javier Mar ◽

Lorea Mar-Barrutia ◽

Vicente Gimeno-Ballester ◽

Ramón San Miguel

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Advanced Fibrosis ◽

Genotype 1 ◽

Effectiveness Analysis

Download Full-text